Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. News
  7. Summary
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ZUR ROSE GROUP : Jefferies reiterates its Buy rating

10/21/2021 | 06:38am EST

Analyst Alexander Thiel from Jefferies research considers the stock attractive and recommends it with a Buy rating. The target price continues to be set at CHF 571.


ę MarketScreener with dpa-AFX Analyser 2021
All news about ZUR ROSE GROUP AG
11:20aZUR ROSE : EHealth-Tec achieves first place in the TOP 100 competition
PU
11/25ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
11/05ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
10/28Roche, Zur Rose Partner for Diabetes Management Project
MT
10/28Roche and the Zur Rose Group announce collaboration to offer innovative health journeys..
PU
10/25ZUR ROSE GROUP : Gets a Sell rating from UBS
MD
10/22ZUR ROSE GROUP : Baader Bank maintains a Buy rating
MD
10/22ZUR ROSE GROUP : UBS maintains a Sell rating
MD
10/22ZUR ROSE GROUP : Receives a Buy rating from Warburg Research
MD
10/21ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
More news
Analyst Recommendations on ZUR ROSE GROUP AG
More recommendations
Financials
Sales 2021 1 716 M 1 852 M 1 852 M
Net income 2021 -158 M -171 M -171 M
Net Debt 2021 388 M 419 M 419 M
P/E ratio 2021 -23,1x
Yield 2021 -
Capitalization 3 510 M 3 803 M 3 788 M
EV / Sales 2021 2,27x
EV / Sales 2022 1,66x
Nbr of Employees 1 960
Free-Float 88,2%
Chart ZUR ROSE GROUP AG
Duration : Period :
Zur Rose Group AG Technical Analysis Chart | ROSE | CH0042615283 | MarketScreener
Technical analysis trends ZUR ROSE GROUP AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 366,00 CHF
Average target price 442,63 CHF
Spread / Average Target 20,9%
EPS Revisions
Managers and Directors
Walter Oberhńnsli Chief Executive Officer & Executive Director
Marcel Ziwica Chief Financial Officer
Stefan Feuerstein Chairman
Madhu Nutakki Chief Technology Officer
Bernd Michael Gschaider Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZUR ROSE GROUP AG19.08%3 453
WALGREENS BOOTS ALLIANCE, INC.15.10%40 355
MCKESSON CORPORATION27.42%34 509
JD HEALTH INTERNATIONAL INC.-54.20%28 709
CARDINAL HEALTH, INC.-8.92%13 746
WELCIA HOLDINGS CO., LTD.7.96%7 451